Aug 5, 2025
Tentative Approval for Generic Lumateperone capsules
Jul 10, 2025
CDP Recognition
Jun 24, 2025
Dr. Reddys API team at CPHI China 2025
Apr 9, 2025
CPHI Japan 2025 - Exhibitor showcase session by Nirav K Shah, Vice President, Head API, North Asia
Apr 9, 2025
Dr. Reddys API team at CPHI Japan 2025
Mar 17, 2025
Dr. Reddys API team at DCAT 2025
Feb 25, 2025
Dr. Reddy’s Wins Big at “Express Pharma Excellence Awards 2025”
Dec 18, 2024
Celebrating Creativity and Festivity: API Calendar Launch 2025!
Nov 29, 2024
Dr. Reddy’s wins CPHI & PMEC India Award for Excellence in Ancillary Pharma Services - Supply Chain & Logistics for enhancing customer experience
Nov 29, 2024
Dr. Reddy’s wins CPHI & PMEC India Award for developing a continuous API manufacturing process.
Nov 29, 2024
Dr. Reddy's API team at CPHI India 2024
Oct 13, 2024
Dr. Reddy's API team at CPHI Milan 2024
Sep 27, 2024
Gunjan Singh at the CPHI Webinar: The Changing Dynamics of Global API Manufacturing
Sep 27, 2024
Karun Gaur at CPHI Milan: Panel Discussion on Pharma Manufacturing in Emerging Markets - Moving Towards Localization in Africa
Jul 8, 2024
Deepak Sapra's Visionary Keynote on Healthcare Innovation at DXEM 2024
May 8, 2024
Dr. Reddy's AI Day: Igniting the Future of Healthcare with Innovation
Apr 25, 2024
USP recognized Dr. Reddy’s with a crystal award for significant contribution towards “New and modernized monograph submissions”
Apr 22, 2024
Dr. Reddy’s API at CPHI Japan 2024
Apr 5, 2024
Dr. Reddys Strategic collaboration with Industrial Promotion Services (IPS) to support the East African Combined Pharmaceutical Center (EACPC) in Kenya
Jan 2, 2024
Dr. Reddy's API Calendar 2024 Unveiling: A Magical Celebration of Creativity, Joy, and Togetherness with Our Global Team's Talented Young Artists
Dec 5, 2023
Dr. Reddy's Pioneers Pharma Advancements Through Strategic Partnerships and Innovation: A Glimpse into Vision 2030: Growth Trajectory and Opportunities for Indian Pharma
Nov 30, 2023
Dr. Reddy’s at CPHI India 2023
Nov 23, 2023
Dr. Reddy’s at 5th CII LIFE SCIENCES SUMMIT 2023 - Making India a Global Pharma and Lifesciences Innovation Hub
Nov 11, 2023
Asia-Pacific Climate Leader Award
Nov 10, 2023
Dr. Reddy’s Achieves AEO-T3 Certification, Elevating Global Trade Facilitation
Oct 28, 2023
Dr. Reddy’s API at CPHI Worldwide 2023
Aug 20, 2023
Dr. Reddys at G20 Summit 2023
Jun 25, 2023
Dr. Reddy’s API at CPHI China 2023
Mar 15, 2023
Being Prepared for What's Next and a Shared Purpose of Serving Patients Whatever it Takes
Feb 15, 2023
Dr. Reddy’s included in Bloomberg Gender-Equality Index for the 6th year in a row and S&P Global’s Sustainability Yearbook for the 3rd year
Jan 5, 2023
Dr. Reddy's API calendar 2023
Nov 6, 2022
Addressing NDMAs in Pharmaceuticals
Nov 5, 2022
Dr.Reddy's at CPHI India 2022 Panel Discussion
Nov 4, 2022
Dr. Reddy’s API received the excellence in API – Technical Documentation award at Aché Laboratórios Parcerias para a Excelência (Partnerships – Excellence) event!
Oct 6, 2022
Dr. Reddy's API participated in the 2022 Pharmaceutical Industry and Regulators Symposium at ANVISA
Sep 27, 2022
Expert statement by Srividya Ramakrishnan, Head, API process engineering, Dr. Reddy’s Laboratories. Published in CHE Manager
Sep 25, 2022
Dr. Reddys attended ACHEMA 2022 Conference
Nov 11, 2021
Dr. Reddy’s API team is a 2021 winner in – API Supplier of the year at Global generics & Biosimilars awards
Nov 11, 2022
COVID-19: Prime Minister of India Meets Pharma leaders
Nov 11, 2021
The winner of the Corporate social responsibility (CSR) Initiative of the year at Global generics & Biosimilars Awards
Oct 7, 2021
The winner of the Best Indian Company in the US - Manufacturing Sector for the year 2021
Oct 6, 2021
Sugammadex Sodium API – CADIFA Approval by ANVISA
May 27, 2021
Deepak Sapra speaks about DRDO’s anti-covid drug 2DG
May 27, 2021
Dr.Reddy’s gearing up with Covid portfolio: Deepak Sapra, CEO of API & Services, speaks to India Today
Jan 21, 2021
Best Supply Chain Team of the Year - Pharma- 2021
Nov 10, 2020
Dr. Reddy’s Laboratories’ Anil Patni presented on HPAPIs at Manufacturing Chemist Live Virtual
Nov 3, 2020
Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2020
Oct 19, 2020
Dr. Reddy's recognized at the CPhI Pharma Awards 2020 as the winner in the category of ‘Excellence in Pharma: Sustainability’
Oct 13, 2020
CPhI Festival of Pharma Roundtable: Tackling Nitrosamine Contamination
Oct 5, 2020
Dr. Reddy’s Laboratories joins Science Based Targets initiative (SBTi) and sets 2030 GHG emission targets
Oct 5, 2020
CPhI Festival of Pharma Panel discussion: Innovation Across Borders: How Pharma and innovators are fighting Back Against COVID-19 and ways forward.
Jul 1, 2020
Dr. Reddy’s partners with FUJIFILM and Global Response Aid for Avigan® (favipiravir), a potential treatment of COVID-19
Apr 14, 2020
Dr. Reddy’s statement on the COVID-19 pandemic
Apr 1, 2020
Dr. Reddy’s is featured in an article of Global Pharma Insights on “Nitrosamine contamination: pharma’s re-evaluation of its supply chain”
Apr 1, 2020
Certificate of Suitability (CEP) granted for Levofloxacin Hemihydrate
Mar 1, 2020
US DMF for Apalutamide - Now available
Mar 1, 2020
Dr. Reddy's Sustainability Report 2018-19
Dec 1, 2019
Dr. Reddy's API Team moves into its new office in China
Nov 1, 2019
Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2019
免責事項
このウェブサイト上のいかなる情報も、製品またはサービスへの言及を含め、販売の申し出を構成するものではなく、販売の申し出を表すものと解釈されるものでもありません。有効な特許により保護されている製品は、商用目的で提供または提供されるものではありません。ただし、特定のケースでは、Dr. Reddy の独自の裁量により、現地の法的要件に従って、そのような製品の研究用数量が、規制免除が存在する場所に、インド特許法第 107A 条 (Bolar 免除) に基づく規制提出の目的で提供される場合があります。購入者は、それぞれの市場における特許シナリオを含む製品またはサービスについて独自の評価を行う必要があり、すべての特許関連法的責任を負うことになります。Dr. Reddy は、商品性、特定目的への適合性、および非侵害の保証を含むがこれらに限定されない、明示または黙示を問わずすべての保証を否認します。